Indaptus Therapeutics, Inc.(INDP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INDP Indaptus Therapeutics, Inc.

盘前交易 07-22 04:49:16 EDT

2.13

-0.01

-0.47%

最高2.19	最低2.13	成交量1,563
今开2.19	昨收2.14	日振幅2.80%
总市值1,819万	流通市值1,257万	总股本853.89万
成交额3,374	换手率0.03%	流通股本590.28万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"INDP","market":"US","secType":"STK","nameCN":"Indaptus Therapeutics, Inc.","latestPrice":2.13,"timestamp":1721419200000,"preClose":2.14,"halted":0,"volume":1563,"delay":0,"floatShares":5902782,"shares":8538883,"eps":-1.780554,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.01,"latestTime":"07-22 04:49:16 EDT","open":2.19,"high":2.19,"low":2.13,"amount":3374.0801414999996,"amplitude":0.028037,"askPrice":2.94,"askSize":100,"bidPrice":1.93,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.780554,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721655000000},"adr":0,"listingDate":1438660800000,"adjPreClose":2.13,"postHourTrading":{"tag":"盘后","latestPrice":2.13,"preClose":2.13,"latestTime":"17:57 EDT","volume":21,"amount":43.98,"timestamp":1721426247351},"volumeRatio":0.23049018280817876},"requestUrl":"/m/hq/s/INDP","defaultTab":"news","newsList":[{"id":"2450443638","title":"Indaptus Therapeutics, Inc.盘中异动 股价大涨5.19%报2.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450443638","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450443638?lang=zh_cn&edition=full","pubTime":"2024-07-11 02:33","pubTimestamp":1720636392,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日02时33分，Indaptus Therapeutics, Inc.股票出现波动，股价快速上涨5.19%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.51%。其相关个股中，Kazia Therapeutics Limited、Virpax Pharmaceuticals, Inc.、Longeveron Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为4110.40%、1541.86%、1341.58%，振幅较大的相关个股有Kazia Therapeutics Limited、Revolution Medicines Inc C/Wts 17/12/2026 、Virpax Pharmaceuticals, Inc.，振幅分别为421.88%、133.16%、130.17%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711023312941f5e19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711023312941f5e19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","INDP"],"gpt_icon":0},{"id":"2441208474","title":"Indaptus Therapeutics, Inc.盘中异动 临近午盘股价大跌5.02%报2.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441208474","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441208474?lang=zh_cn&edition=full","pubTime":"2024-06-05 23:37","pubTimestamp":1717601834,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日23时37分，Indaptus Therapeutics, Inc.股票出现波动，股价急速下挫5.02%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.28%。其相关个股中，Virios Therapeutics, Inc.、诺瓦瓦克斯医药、Kineta, Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Adial Pharmaceuticals, Inc、Virios Therapeutics, Inc.较为活跃，换手率分别为68.47%、50.73%、46.83%，振幅较大的相关个股有Virios Therapeutics, Inc.、Kineta, Inc.、Biocardia Inc C/Wts 06/08/2024，振幅分别为66.83%、63.28%、41.80%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605233715941ec9b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605233715941ec9b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","INDP"],"gpt_icon":0},{"id":"2438377587","title":"Indaptus Therapeutics, Inc.盘中异动 股价大涨5.13%报2.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2438377587","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438377587?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:30","pubTimestamp":1716903025,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时30分，Indaptus Therapeutics, Inc.股票出现异动，股价快速拉升5.13%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Exicure, Inc.、Nutriband Inc C/Wts 、Cytomx Therapeutics, Inc.涨幅较大，Exicure, Inc.、Nls Pharmaceutics Ltd.、Jaguar Health, Inc.较为活跃，换手率分别为17.18%、7.23%、6.46%，振幅较大的相关个股有Renovorx, Inc.、Novabay Pharmaceuticals, Inc.、Cybin Inc.，振幅分别为7.14%、5.24%、2.78%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213026941ea9b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213026941ea9b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","INDP","BK4139"],"gpt_icon":0},{"id":"2437293489","title":"Indaptus Therapeutics, Inc.股价飙升12.77% 市值涨288.96万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437293489","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437293489?lang=zh_cn&edition=full","pubTime":"2024-05-22 21:32","pubTimestamp":1716384722,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日21时32分，Indaptus Therapeutics, Inc.股票出现异动，股价大幅上涨12.77%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Mustang Bio, Inc.、Rezolute, Inc.涨幅较大，Mustang Bio, Inc.、Biodexa Pharmaceuticals Plc、Coeptis Therapeutics Holdings, Inc.较为活跃，换手率分别为183.97%、89.60%、32.34%，振幅较大的相关个股有Rezolute, Inc.、Nutriband Inc C/Wts 、Sol-Gel Technologies Ltd.，振幅分别为13.00%、12.90%、10.55%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052221320295503e6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052221320295503e6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INDP","BK4139","LENZ"],"gpt_icon":0},{"id":"2432801601","title":"Indaptus Therapeutics, Inc.盘中异动 早盘股价大涨6.11%报2.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432801601","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432801601?lang=zh_cn&edition=full","pubTime":"2024-05-02 21:32","pubTimestamp":1714656760,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日21时32分，Indaptus Therapeutics, Inc.股票出现波动，股价急速上涨6.11%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.涨幅较大，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.较为活跃，换手率分别为1515.37%、302.91%、83.03%，振幅较大的相关个股有Allarity Therapeutics, Inc.、Zura Bio Limited C/Wts 、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为30.66%、22.07%、18.71%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050221324187e85539&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050221324187e85539&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INDP","LENZ","BK4139"],"gpt_icon":0},{"id":"2432577460","title":"Indaptus Therapeutics, Inc.盘中异动 股价大涨5.07%报2.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432577460","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432577460?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:30","pubTimestamp":1714570254,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时30分，Indaptus Therapeutics, Inc.股票出现波动，股价大幅上涨5.07%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Cytomx Therapeutics, Inc.、Palisade Bio, Inc.、Tg Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为342.03%、23.80%、12.14%，振幅较大的相关个股有Dare Bioscience, Inc.、Igc Pharma, Inc.、Theriva Biologics, Inc.，振幅分别为7.15%、6.09%、4.72%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240501213054861ea844&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240501213054861ea844&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INDP","LENZ","BK4139"],"gpt_icon":0},{"id":"2432780115","title":"Indaptus Therapeutics Inc   预计每股亏损57美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432780115","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432780115?lang=zh_cn&edition=full","pubTime":"2024-05-01 20:03","pubTimestamp":1714564983,"startTime":"0","endTime":"0","summary":"   * Indaptus Therapeutics Inc    预计将于5月3日公布截至2024年3月31日的财报(估计)。*    * LSEG分析师对Indaptus Therapeutics Inc的平均预期是每股亏损57美分。* 华尔街对 Indaptus Therapeutics Inc 的 12 个月目标价中位数为 10.00 美元，高于其最新收盘价 2.17 美元。5月1日 - 本摘要于北京时间5月1日12:02由机器生成。除非另有说明，所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","INDP"],"gpt_icon":0},{"id":"2431664928","title":"Indaptus Therapeutics, Inc.盘中异动 早盘快速上涨6.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431664928","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431664928?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:31","pubTimestamp":1714397491,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时31分，Indaptus Therapeutics, Inc.股票出现异动，股价快速拉升6.64%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Soleno Therapeutics, Inc.、Zyversa Therapeutics, Inc.、Immunitybio, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为401.62%、22.60%、9.66%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Zyversa Therapeutics, Inc.、Calcimedica, Inc.，振幅分别为19.05%、13.83%、10.09%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292131318b624dbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292131318b624dbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INDP","LENZ","BK4139"],"gpt_icon":0},{"id":"2428346584","title":"Indaptus Therapeutics, Inc.盘中异动 早盘股价大跌8.33%报2.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428346584","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428346584?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:45","pubTimestamp":1713361525,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时45分，Indaptus Therapeutics, Inc.股票出现波动，股价急速跳水8.33%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Vanda Pharmaceuticals Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Clearmind Medicine Inc.、Longeveron Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为25.91%、25.20%、24.73%，振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Cassava Sciences Inc C/Wts 15/11/2024、Igc Pharma, Inc.，振幅分别为27.34%、26.44%、25.51%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417214525861e6b78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417214525861e6b78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","INDP"],"gpt_icon":0},{"id":"2426295873","title":"Indaptus Therapeutics, Inc.盘中异动 下午盘快速上涨5.16%报2.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426295873","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426295873?lang=zh_cn&edition=full","pubTime":"2024-04-12 01:33","pubTimestamp":1712856811,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日01时33分，Indaptus Therapeutics, Inc.股票出现异动，股价大幅拉升5.16%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。其相关个股中，Rallybio Corporation、Eliem Therapeutics, Inc、Candel Therapeutics, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Aptevo Therapeutics Inc.、Scisparc Ltd.较为活跃，换手率分别为774.76%、576.28%、512.07%，振幅较大的相关个股有Veru Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Rallybio Corporation，振幅分别为53.23%、52.42%、50.92%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412013331791ff5f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412013331791ff5f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INDP","BK4139","LENZ"],"gpt_icon":0},{"id":"2422517777","title":"Indaptus Therapeutics, Inc.盘中异动 早盘快速跳水7.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422517777","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422517777?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:32","pubTimestamp":1711373527,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日21时32分，Indaptus Therapeutics, Inc.股票出现异动，股价大幅下跌7.33%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Landos Biopharma, Inc.、Altamira Therapeutics Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Altamira Therapeutics Ltd.、Salarius Pharmaceuticals, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为854.53%、47.17%、31.07%，振幅较大的相关个股有Altamira Therapeutics Ltd.、Xtl生物制药、Ocugen, Inc.，振幅分别为21.97%、15.26%、8.53%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032521320787b341f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032521320787b341f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INDP","LENZ","BK4139"],"gpt_icon":0},{"id":"2420740587","title":"Indaptus Therapeutics, Inc.盘中异动 早盘大幅拉升7.07%报2.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420740587","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420740587?lang=zh_cn&edition=full","pubTime":"2024-03-20 21:34","pubTimestamp":1710941697,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日21时34分，Indaptus Therapeutics, Inc.股票出现异动，股价快速拉升7.07%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。其相关个股中，Jaguar Health, Inc.、Taysha Gene Therapies, Inc.、Immuneering Corporation涨幅较大，Jaguar Health, Inc.、Tc Biopharm  Plc、Nls Pharmaceutics Ltd.较为活跃，换手率分别为38.42%、30.28%、14.84%，振幅较大的相关个股有Jaguar Health, Inc.、Taysha Gene Therapies, Inc.、Design Therapeutics, Inc.，振幅分别为18.43%、18.05%、10.81%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320213457861dfc18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320213457861dfc18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INDP","BK4139"],"gpt_icon":0},{"id":"2417907422","title":"Indaptus Therapeutics, Inc.盘中异动 快速下跌6.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417907422","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417907422?lang=zh_cn&edition=full","pubTime":"2024-03-06 22:59","pubTimestamp":1709737185,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日22时59分，Indaptus Therapeutics, Inc.股票出现波动，股价快速下跌6.35%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Biomx Inc.、知临集团、Nkgen Biotech, Inc.涨幅较大，Creative Medical Technology Holdings, Inc.、知临集团、Biomx Inc.较为活跃，换手率分别为177.59%、175.82%、172.15%，振幅较大的相关个股有Biomx Inc.、知临集团、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为93.03%、74.26%、70.90%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403062259457a4a1f21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403062259457a4a1f21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INDP","BK4139"],"gpt_icon":0},{"id":"2415472605","title":"Indaptus Therapeutics, Inc.盘中异动 早盘股价大涨5.05%报2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415472605","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2415472605?lang=zh_cn&edition=full","pubTime":"2024-02-29 22:30","pubTimestamp":1709217045,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日22时30分，Indaptus Therapeutics, Inc.股票出现波动，股价大幅上涨5.05%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Enveric Biosciences, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Avidity Biosciences, Inc.涨幅较大，Enveric Biosciences, Inc.、Scisparc Ltd.、Neurobo Pharmaceuticals, Inc.较为活跃，换手率分别为1627.96%、51.66%、48.72%，振幅较大的相关个股有Enveric Biosciences, Inc.、Neubase Therapeutics, Inc.、Coeptis Therapeutics Holdings, Inc.，振幅分别为15.63%、8.68%、6.88%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402292230457915f817&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402292230457915f817&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INDP","BK4139"],"gpt_icon":0},{"id":"2414183521","title":"Indaptus Therapeutics Inc盘中异动 快速下挫5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414183521","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2414183521?lang=zh_cn&edition=full","pubTime":"2024-02-26 22:46","pubTimestamp":1708958771,"startTime":"0","endTime":"0","summary":"北京时间2024年02月26日22时46分，Indaptus Therapeutics Inc股票出现波动，股价急速下跌5.49%。Indaptus Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Ys Biopharma Co Ltd C/Wts 15/03/2028 、Carmell Corp、Altimmune Inc涨幅较大，Lixte Biotechnology Holdings  Inc、Neubase Therapeutics Inc、Kintara Therapeutics Inc较为活跃，换手率分别为59.90%、49.96%、47.22%，振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Portage Biotech Inc，振幅分别为48.55%、30.27%、23.96%。Indaptus Therapeutics Inc公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402262246128ae24dc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402262246128ae24dc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INDP"],"gpt_icon":0},{"id":"2413148766","title":"Indaptus Therapeutics Inc   预计每股亏损54美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2413148766","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2413148766?lang=zh_cn&edition=full","pubTime":"2024-02-23 21:39","pubTimestamp":1708695560,"startTime":"0","endTime":"0","summary":"   * Indaptus Therapeutics Inc    预计将于2月26日公布截至2023年12月31日的财报(估计)    *    * LSEG分析师对Indaptus Therapeutics Inc的平均预期是每股亏损54美分。* 目前，分析师对该公司股票的平均评级为 \"买入\"，建议分类为2个 \"强烈买入 \"或 \"买入\"，没有 \"持有\"，也没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Indaptus Therapeutics Inc 的 12 个月目标价中位数为 10.00 美元，高于其最新收盘价 1.91 美元。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDP"],"gpt_icon":0},{"id":"2413309429","title":"Indaptus Therapeutics Inc盘中异动 早盘股价大跌5.23%报1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413309429","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2413309429?lang=zh_cn&edition=full","pubTime":"2024-02-21 22:34","pubTimestamp":1708526094,"startTime":"0","endTime":"0","summary":"北京时间2024年02月21日22时34分，Indaptus Therapeutics Inc股票出现异动，股价快速下挫5.23%。截至发稿，该股报1.61美元/股，成交量340股，换手率0.00%，振幅0.00%。Indaptus Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.04%。Indaptus Therapeutics Inc公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402212234547a455e5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402212234547a455e5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INDP"],"gpt_icon":0},{"id":"2410056153","title":"Indaptus Therapeutics Inc盘中异动 股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2410056153","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2410056153?lang=zh_cn&edition=full","pubTime":"2024-02-09 22:31","pubTimestamp":1707489095,"startTime":"0","endTime":"0","summary":"北京时间2024年02月09日22时31分，Indaptus Therapeutics Inc股票出现波动，股价大幅跳水5.29%。Indaptus Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Xenetic Biosciences Inc C/Wts 19/07/2024 、Tc Biopharm  Plc、Centessa Pharmaceuticals Plc涨幅较大，Tc Biopharm  Plc、Tenax Therapeutics Inc、Transcode Therapeutics Inc较为活跃，换手率分别为1453.59%、21.18%、11.96%，振幅较大的相关个股有Tc Biopharm  Plc、Clene Inc、Okyo Pharma Ltd Com Npv ，振幅分别为16.36%、11.13%、10.49%。Indaptus Therapeutics Inc公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240209223135817d7df1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240209223135817d7df1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INDP"],"gpt_icon":0},{"id":"2408565656","title":"Indaptus Therapeutics Inc盘中异动 临近午盘股价大涨7.78%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2408565656","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2408565656?lang=zh_cn&edition=full","pubTime":"2024-02-01 00:44","pubTimestamp":1706719491,"startTime":"0","endTime":"0","summary":"北京时间2024年02月01日00时44分，Indaptus Therapeutics Inc股票出现异动，股价大幅拉升7.78%。截至发稿，该股报1.80美元/股，成交量6962股，换手率0.08%，振幅6.57%。Indaptus Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.40%。Indaptus Therapeutics Inc公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020100445187e6aa52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020100445187e6aa52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INDP","BK4139"],"gpt_icon":0},{"id":"2404354646","title":"Indaptus Therapeutics Inc盘中异动 股价大涨6.17%报1.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2404354646","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2404354646?lang=zh_cn&edition=full","pubTime":"2024-01-17 22:52","pubTimestamp":1705503137,"startTime":"0","endTime":"0","summary":"北京时间2024年01月17日22时52分，Indaptus Therapeutics Inc股票出现波动，股价急速上涨6.17%。截至发稿，该股报1.88美元/股，成交量1146股，换手率0.01%，振幅0.00%。Indaptus Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.38%。Indaptus Therapeutics Inc公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401172252187909bc9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401172252187909bc9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INDP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.indaptusrx.com","stockEarnings":[{"period":"1week","weight":-0.0533},{"period":"1month","weight":-0.1446},{"period":"3month","weight":-0.0975},{"period":"6month","weight":0.1833},{"period":"1year","weight":0.1094},{"period":"ytd","weight":0.2102}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Indaptus Therapeutics, Inc.于2021年2月24日在特拉华州注册成立。这是一个临床阶段的生物制药公司，专注于开发基于它专有的Accordion Pill平台技术。Indaptus的专利技术由单一菌株的减毒和杀灭的非致病性革兰氏阴性细菌组成，具有降低的静脉毒性，但在很大程度上具有激发或激活先天免疫和适应性免疫的许多细胞成分的不妥协能力。这种方法产生了广泛的抗肿瘤和抗病毒活性，包括安全、持久的抗肿瘤反应协同效应与五种不同的现有药物，包括检查点治疗、靶向抗体治疗和临床前模型中的低剂量化疗。通过Indaptus技术根除肿瘤已经证明了先天性和适应性免疫记忆的激活，重要的是，在临床前模型中不需要提供或靶向肿瘤抗原。Indaptus已成功生产了其主要临床候选药物Decoy20的GMP，目前正在完成其他IND使能研究。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":-0.027434},{"month":2,"riseRate":0.444444,"avgChangeRate":0.014519},{"month":3,"riseRate":0.555556,"avgChangeRate":-0.025686},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.016408},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.032542},{"month":6,"riseRate":0.444444,"avgChangeRate":-0.014205},{"month":7,"riseRate":0.555556,"avgChangeRate":-0.045484},{"month":8,"riseRate":0.5,"avgChangeRate":0.095393},{"month":9,"riseRate":0.444444,"avgChangeRate":0.021695},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.117959},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.021385},{"month":12,"riseRate":0.444444,"avgChangeRate":-0.047011}],"exchange":"NASDAQ","name":"Indaptus Therapeutics, Inc.","nameEN":"Indaptus Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Indaptus Therapeutics, Inc.(INDP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Indaptus Therapeutics, Inc.(INDP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Indaptus Therapeutics, Inc.,INDP,Indaptus Therapeutics, Inc.股票,Indaptus Therapeutics, Inc.股票老虎,Indaptus Therapeutics, Inc.股票老虎国际,Indaptus Therapeutics, Inc.行情,Indaptus Therapeutics, Inc.股票行情,Indaptus Therapeutics, Inc.股价,Indaptus Therapeutics, Inc.股市,Indaptus Therapeutics, Inc.股票价格,Indaptus Therapeutics, Inc.股票交易,Indaptus Therapeutics, Inc.股票购买,Indaptus Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Indaptus Therapeutics, Inc.(INDP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Indaptus Therapeutics, Inc.(INDP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}